Enhanced tumorigenesis of forestomach tumors induced by N-Methyl-N′-nitro-N-nitrosoguanidine in rats with hypoinsulinemic diabetes

Cancer Science

Volumn 101, Issue 7, 2010, Pages 1604-1609

  Kodama, Yasushi ^a   Ozaki, Kiyokazu ^b   Sano, Tomoya ^b   Matsuura, Tetsuro ^b   Narama, Isao ^b  

^a HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; KI 67 ANTIGEN; METHYLNITRONITROSOGUANIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FORESTOMACH TUMOR; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HISTOPATHOLOGY; HYPERINSULINEMIA; HYPOINSULINEMIC DIABETES; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; RAT; SQUAMOUS EPITHELIUM; STOMACH TUMOR; TUMOR VOLUME; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; CARCINOGENS; CARCINOMA; DIABETES MELLITUS, EXPERIMENTAL; EPITHELIAL CELLS; GASTRIC MUCOSA; INSULIN; KI-67 ANTIGEN; MALE; METHYLNITRONITROSOGUANIDINE; PANCREATITIS; PAPILLOMA; RATS; RATS, INBRED STRAINS; RATS, WISTAR; STOMACH; STOMACH NEOPLASMS;

EID: 77954648692     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01589.x     Document Type: Article

References (29)

1. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006, 166:1871-7.
2. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005, 293:194-202.
3. Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995, 4:807-11.
4. Strickler HD, Wylie-Rosett J, Rohan T. The relation of type 2 diabetes and cancer. Diabetes Technol Ther 2001, 3:263-74.
5. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci 2002, 323:140-5.
6. Dandona P, Thusu K, Cook S. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-5.
7. Dankner R, Chetrit A, Segal P. Glucose tolerance status and 20 year cancer incidence. Isr Med Assoc J 2007, 9:592-6.
8. Krone CA, Ely JT. Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 2005, 4:25-31.
9. Lorenzi M, Montisano DF, Toledo S, Barrieux A. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 1986, 77:322-5.
10. Yamagata H, Kiyohara Y, Nakamura S. Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study. Diabetes Care 2005, 28:789-94.
11. Adami HO, Trichopoulos D. Obesity and mortality from cancer. N Engl J Med 2003, 348:1623-4.
12. Vigneri P, Frasca F, Sciacca L, Frittitta L, Vigneri R. Obesity and cancer. Nutr Metab Cardiovasc Dis 2006, 16:1-7.
13. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer 2009, 16:1103-23.
14. Bell RH, Brinck-Johnsen T, Longnecker DS. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene. Pancreas 1991, 6:475-8.
15. Lauder I, Abascal J, Cartwright RA, Farndon JR, Johnston ID. Liver tumours following streptozotocin administration in rats and the effects of pancreatic islet cell transplantation. Carcinogenesis 1981, 2:799-803.
16. Vairaktaris E, Spyridonidou S, Goutzanis L. Diabetes and oral oncogenesis. Anticancer Res 2007, 27:4185-93.
17. Gabridge MG, Denunzio A, Legator MS. Microbial mutagenicity of streptozotocin in animal-mediated assays. Nature 1969, 221:68-70.
18. Yamasaki K, Hayashi Y, Okamoto S, Osanai M, Lee GH. Insulin-independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice. Cancer Sci 2010, 101:65-72.
19. Tsuchitani M, Saegusa T, Narama I, Nishikawa T, Gonda T. A new diabetic strain of rat (WBN/Kob). Lab Anim 1985, 19:200-7.
20. Nakama K, Shichinohe K, Kobayashi K. Spontaneous diabetes-like syndrome in WBN/KOB rats. Acta Diabetol Lat 1985, 22:335-42.
21. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003, 46:595-607.
22. Schiel R, Beltschikow W, Steiner T, Stein G. Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 2006, 28:169-75.
23. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003, 157:1092-100.
24. Kodama Y, Ozaki K, Sano T, Matsuura T, Akagi H, Narama I. Induction of squamous cell carcinoma of forestomach in diabetic rats by single alloxan treatment. Cancer Sci 2006, 97:1023-30.
25. Sano T, Ozaki K, Kodama Y, Matsuura T, Narama I. Prevention of proliferative changes of forestomach mucosa by blood glucose control with insulin in alloxan-induced diabetic rats. Cancer Sci 2009, 100:595-600.
26. Eldridge SR, Goldsworthy SM. Cell proliferation rates in common cancer target tissues of B6C3F1 mice and F344 rats: effects of age, gender, and choice of marker. Fundam Appl Toxicol 1996, 32:159-67.
27. Kimura M, Fukuda T, Sato K. Effect of aging on the development of gastric cancer in rats induced by N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1979, 70:521-5.
28. Vairaktaris E, Kalokerinos G, Goutzanis L. Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis. Int J Oral Maxillofac Surg 2008, 37:60-5.
29. Sano T, Ozaki K, Kodama Y, Matsuura T, Narama I. Paradoxical effects of a selective cyclooxygenase-2 inhibitor, etodolac, on proliferative changes of forestomach in alloxan-induced diabetic rats. Exp Toxicol Pathol 2009, 61:371-80.